Lee Mainwaring, Finance Director of Penn Pharmaceutical Services said, "We are delighted that Penn continues to go from strength to strength and we plan to continue to grow the business by more than 20% year on year. Over the coming months, we anticipate further growth by introducing new business initiatives which include the production of high potency drugs and extending our temperature controlled facilities to support our Clinical Trial Supply (CTS) and Storage and Distribution services. We have also recently opened a US office, as this is a key market for Penn, we already work with US companies who need clinical trial supply and manufacture, as well as import and QP release of pharmaceutical products into the European market." Penn is a leading provider of fully integrated and cost effective pharmaceutical development and custom manufacturing services to the international health care industry. Penn’s services support a fast and effective route from clinic to market. Penn provides unparalleled service offerings, developed over its 30 year trading history, which are individually excellent and compelling in combination. Penn’s Services include formulation and analytical development, clinical trial supplies, packing, storage, distribution and inventory management, specialised custom manufacturing, from pilot to commercial batch sizes, CMC consultancy and QP services. Penn has global reach through an international sales force and strategic alliances for its services offered from its single site operation in South Wales. Penn operates quality systems, proven through audit and compliance with GMP. Penn is licensed by MHRA for manufacturing (including IMPs and Specials), importation and distribution and also by FDA for certain drug manufacturing and assembly of medical devices. Penn is licensed by the UK Home Office for the importation, storage and distribution of controlled drugs. In addition Penn is accredited as an Investors in People (IIP) and ISO14001 organisation. Penn employs more than 200 people and operates from a 323,000 sq ft base in Tredegar, South Wales. It provides a variety of technically-demanding services to the pharmaceutical industry through three core divisions.